Drug Shortage Report for CANTHACUR-PS
Report ID | 12045 |
Drug Identification Number | 00589500 |
Brand name | CANTHACUR-PS |
Common or Proper name | Canthacur |
Company Name | PALADIN LABS INC. |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | SALICYLIC ACID CANTHARIDIN PODOPHYLLIN |
Strength(s) | 30% 1% 5% |
Dosage form(s) | LIQUID |
Route of administration | TOPICAL |
Packaging size | 7.5ml |
ATC code | D11 |
ATC description | OTHER DERMATOLOGICAL PREPARATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2017-06-06 |
Actual start date | 2017-06-06 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2020-06-17 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 100 BLVD ALEXIS-NIHON, SUITE 600 SAINT-LAURENT, QUEBEC CANADA H4M 2P2 |
Company contact information | 1-866-340-1112 paladincs@endo.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-06-06 | English | Compare |
v2 | 2017-06-06 | French | Compare |
v3 | 2017-06-07 | English | Compare |
v4 | 2017-11-24 | English | Compare |
v5 | 2017-11-24 | French | Compare |
Showing 1 to 5 of 5